It's normal to feel a great burden when a doctor tells you, or someone you know, that you have a kidney problem, especially a condition called IgA Nephropathy (IgAN). This is a disease that damages the kidneys due to a small mistake in our body's own immune system. So today we are going to talk about this disease and the newly introduced drug called Vanrafia, very simply.
What exactly is IgA nephropathy (IgAN)?
Simply put, IgA nephropathy (IgAN) is an autoimmune disease. Sometimes called Berger's disease , it occurs when antibodies , specifically a type of protein called Immunoglobulin A (IgA), build up in the kidneys and form small clumps.
Imagine that our body's security guards have gone astray and set up camp inside our own kidneys. These antibodies cause inflammation in the kidneys' delicate filtering system, and over time, the kidneys gradually begin to become damaged (nephropathy). This damage prevents the kidneys from properly filtering waste from the body.
Vanrafia is a new drug approved to treat patients with IgAN who are at risk of developing a serious condition. It belongs to a class of drugs called endothelin receptor antagonists. These drugs work by blocking receptors that pick up messages that cause inflammation and damage to the kidneys. It's like stopping a harmful message from getting to the right place.
How is IgAN usually managed?
The Kidney Disease Initiative Group (KDIGO) is making recommendations on the best ways to treat diseases like IgAN. Here are some of their key recommendations.
The most important thing is that all of these treatments are determined by the doctor who examines your condition. Therefore , never start or stop taking any medication without medical advice.
Below are the main treatment methods currently used and their goals.
| The purpose of the treatment method | Description and examples |
|---|---|
| Controlling blood pressure | It is important to keep blood pressure below 130 mm Hg (upper limit) in IgAN patients. Various medications are used for this purpose. Examples: - ACE inhibitors (e.g. Captopril, Lisinopril) - ARBs (e.g. Losartan, Valsartan) - Calcium channel blockers (e.g. Amlodipine, Nifedipine) |
| Decreased protein in the urine (Proteinuria) | If you have high levels of protein in your urine (proteinuria), you may be prescribed an ACE inhibitor or ARB, even if you don't have high blood pressure. Sometimes, medications called SGLT2 inhibitors (e.g., Dapagliflozin, Empagliflozin) are also used. |
| Lifestyle changes | Reducing salt in the diet, exercising, quitting smoking, and controlling weight are all important for controlling blood pressure and overall health. |
| Reducing the risk of heart disease | Along with a healthy lifestyle, it is also recommended to reduce the risk of heart disease by using cholesterol-lowering medications if necessary. |
The drug Vanrafia is approved for "high-risk" patients who have high levels of protein in their urine (more than 0.75 - 1 gram per day) despite following the above treatments for at least three months.
How was the success of the Vanrafia drug tested?
The ALIGN clinical trial studied the efficacy and safety of Vanrafia in patients at high risk of developing severe IgAN.
- Who participated?: About 270 patients. Half of them were given the drug Vanrafia, and the other half were given a placebo pill that contained no drug.
- What was measured?: After 36 weeks of treatment, the urine protein-creatinine ratio was measured to see how much it decreased. The higher this ratio, the more kidney damage there is.
The results showed that the urine protein-to-creatinine ratio was reduced by 38% in patients who received Vanrafia, compared with only 3% in those who received placebo. This suggests that Vanrafia significantly reduces protein excretion from the kidneys.
What do we know about the long-term effects of this drug?
Vanrafia is a drug approved under a process called "accelerated approval." That is, a drug that is made available to patients quickly based on early research results for serious conditions with few other treatment options.
However, after this approval, the pharmaceutical company needs to continue research to prove whether this drug actually reduces kidney damage in the long term. The ALIGN trial is still ongoing. Its long-term results will determine whether this drug will remain on the market or not.
Can there be problems with other medications? (Drug Interactions)
Yes, Vanrafia can interact with some other medications. This may reduce the effectiveness of Vanrafia or increase the side effects.
- Drugs that increase the risk of side effects: The side effects of Vanrafia may increase when taken with drugs in the group called `(OATP)1B1/1B3 inhibitors`.
- Drugs that reduce efficacy: The effectiveness of Vanrafia may be reduced when taken with drugs in the category of CYP3A inducers.
Therefore , it is essential to tell your doctor about all the medications you are taking (including vitamins and traditional medicines). Then he or she can choose the treatment that is most suitable for you.
What you need to know about using Vanrafia during pregnancy
This is a very important point. If Vanrafia is taken during pregnancy, it can cause serious birth defects in the baby.
- If you are a woman of childbearing potential, you should take a pregnancy test to confirm that you are not pregnant before starting Vanrafia.
- If you are pregnant or planning to become pregnant, you should not take this medicine at all.
- It is essential to use a highly effective form of birth control during treatment and for two weeks after stopping treatment. Talk to your doctor or gynecologist about the birth control method that is right for you.
- If your period is late during treatment or you suspect you are pregnant, inform your doctor immediately.
Things to know when taking this medicine
Vanrafia is a specialty medicine. This means that these are expensive, complex medications that are not available at every pharmacy.
The process for getting this medication may be different than getting a regular prescription. Your doctor will inform you about specific locations (such as specialty hospital pharmacies) where you can get this medication and the procedures to follow. You may also need to obtain prior authorization from insurance companies. Your doctor will guide you through all of these steps.
Take-Home Message
- IgA nephropathy (IgAN) is a condition in which the kidneys are damaged by the action of our own immune system.
- Vanrafia is a new drug that helps reduce protein excretion in the urine of patients at high risk of severe disease.
- It is very important to control blood pressure, maintain a healthy lifestyle, and take other medications prescribed by your doctor exactly as prescribed.
- If you are taking Vanrafia, it is imperative that you inform your doctor about all other medications you are taking.
- This medication is very harmful to pregnancy. Effective birth control must be used during treatment and for two weeks after stopping.
- Always talk to your doctor about your condition and treatment, and follow his or her advice.
💬 අදහස් (0)
තවමත් කිසිදු අදහසක් පළ කර නොමැත. ඔබේ අදහස පළමු වරට මෙහි එක් කරන්න.
ඔබේ අදහස එක් කරන්න